Behavioural Variant of Frontotemporal Dementia or Mood Disorder?

• Published in: European psychiatry 2022-06, Vol.65 (S1), p.S453-S454
• Main Authors: Mesquita, B., Paulino, S., Fraga, A., Facucho-Oliveira, J., Espada-Santos, P., Albuquerque, M., Costa, M.
• Format: Article
• Language: English
• Subjects: Abstract; bipolar disorder; Dementia; E-Poster Viewing; Mood disorders
• ISSN: 0924-9338; 1778-3585
• DOI: 10.1192/j.eurpsy.2022.1150

IntroductionThe behavioural variant of frontotemporal dementia (bvFTD) is a devastating neurodegenerative syndrome with its peak in the early sixties at about 13 per 100,00. The diagnosis of bvFTD relies on clinical assessment as patients present executive and behavioural deficits, like apathy, loss of motivation and personality changes. Current diagnosis criteria lack specificity and symptomatic overlap between bvFTD and primary psychiatric disorders (PPD) pose a diagnostic conundrum, with half of bvFTD patients previously receiving a psychiatric diagnosis.ObjectivesThe goal is to discuss the syntomatic overlap of these two entities.MethodsBrief non-systematic literature review on the topic, illustrated by a case-report presentation.ResultsA 69 year old men, retired and single, is committed for thought and behavior disorganization and insomnia. He presented expansive mood but also temporal and spatial disorientation and periods of incongruous speech. This patient’s clinical presentation could both entice a diagnosis of bvFTD but also of an affective disorder, especially since it has been reported that neuropsychiatric presentations, like late-onset psychosis or mania, can be the initial presentation of this form of dementia, particularly in patients with C9orf72 mutations, who often display persecutory or grandiosity delusions.ConclusionsThis clinical case exemplifies the difficulty that lies in differentiating cases of bvFTD from late-onset idiopathic mood or psychotic disorders. It is important to consider that on cognitive assessment patients with bvFTD score significantly worse on executive function tests that PPD patients No disease- modifying therapies are available for patients with bvFTD, therefore drug treatment should focus on the most disruptive or taggable behaviours.DisclosureNo significant relationships.